29 November 2024
CVS Group
plc
("CVS" or
the "Company")
Total Voting
Rights
CVS, one of the UK's leading
providers of integrated veterinary services, announces that, as of
29 November 2024, the Company's total issued share capital
consists of 71,740,184 Ordinary Shares of 0.2p each with each one
carrying one voting right. The Company holds no Ordinary Shares in
treasury and the total number of voting rights is therefore
71,740,184.
This figure may be used by
shareholders as the denominator for the calculations by which they
will determine if they are required to notify their interest, or a
change to their interest, in the Company under the FCA's Disclosure
Guidance and Transparency Rules.
Contacts:
CVS Group plc
via
Camarco
Richard Fairman, CEO
Scott Morrison, Company Secretary
Peel Hunt LLP
(Nominated Adviser & Broker)
+44 (0)20 7418 8900
Christopher Golden / James Steel / Andrew Clark
/ Lalit Bose
Berenberg (Joint
Broker)
+44 (0)20 3207 7800
Toby Flaux / Ben Wright / Ciaran Walsh / Milo
Bonser
Camarco
(Financial
PR)
Geoffrey Pelham-Lane
+44 (0)7733 124
226
Ginny Pulbrook
+44 (0)7961 315 138
About CVS Group
plc (www.cvsukltd.co.uk)
CVS Group is an AIM-listed provider of
veterinary services with operations in the UK, and Australia. CVS
is focused on providing high-quality clinical services to its
clients and their animals, with outstanding and dedicated clinical
teams and support colleagues at the core of its strategy. The Group
now operates c.460 veterinary practices across its two territories,
including specialist referral hospitals and dedicated out-of-hours
sites.
Alongside the core Veterinary Practices division, CVS operates
Laboratories (providing diagnostic services to CVS and third
parties), Crematoria (providing pet cremation and clinical waste
disposal for CVS and third-party practices) and an online retail
business ("Animed Direct"). The Group employs c.9,000 personnel,
including c.2,400 veterinary surgeons and c.3,300
nurses.
